Systemic lupus erythematosus: a case-based presentation of renal, neurologic, and hematologic emergencies

Expert Review of Clinical Immunology
Eric J CampbellRosalind Ramsey-Goldman

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder with systemic manifestations and multiorgan involvement. Although primarily diagnosed, and managed in the outpatient setting, it can occasionally present with life-threatening complications that require rapid assessment and urgent aggressive therapy. Areas covered: In our review, we explore three organ systems that are often affected in SLE, but have the potential to present as medical emergencies; these are the kidney, the central nervous system, and the hematologic system. We take a case-based approach to each clinical scenario, with information given sequentially in order to reflect "real-life" situations where management decisions need to be made with limited information. We review the acute management, pathophysiology, diagnostic approach, and treatment along with a review of the literature, for lupus nephritis presenting as rapidly progressive glomerulonephritis, acute lupus transverse myelitis, and refractory antiphospholipid syndrome. Expert commentary: At the conclusion of each section, we provide an expert commentary regarding each issue, relating to diagnosis, early management, and current evidence behind treatment recommendations.

References

Mar 1, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·F P Schena
Oct 7, 1998·The Australian & New Zealand Journal of Obstetrics & Gynaecology·R F Burrows, E A Burrows
Mar 8, 2002·The New England Journal of Medicine·Jerrold S LevineJoyce Rauch
Sep 19, 2002·Neurology·UNKNOWN Transverse Myelitis Consortium Working Group
Mar 13, 2003·Kidney International·J Charles Jennette
Mar 18, 2003·Immunobiology·Ricard Cervera, Ronald A Asherson
Aug 2, 2003·Lupus·D Alarcón-SegoviaR Roubey
Sep 19, 2003·The New England Journal of Medicine·Michael D Lockshin, Doruk Erkan
Dec 16, 2003·Arthritis and Rheumatism·Doruk ErkanRonald A Asherson
Jan 30, 2004·Journal of the American Society of Nephrology : JASN·Jan J WeeningMichio Nagata
Jan 6, 2005·The Neurologist·Adam I KaplinDouglas A Kerr
Feb 25, 2005·Journal of the American Society of Nephrology : JASN·Tak-Mao ChanUNKNOWN Hong Kong Nephrology Study Group
Nov 25, 2005·The New England Journal of Medicine·Ellen M GinzlerGerald B Appel
Jun 9, 2006·The New England Journal of Medicine·William O CooperWayne A Ray
Jul 6, 2006·Kidney International·C GrootscholtenUNKNOWN Dutch Working Party on Systemic Lupus Erythematosus
Jul 27, 2006·Arthritis and Rheumatism·Silvia BucciarelliUNKNOWN European Forum on Antiphospholipid Antibodies
Dec 1, 2007·Arthritis and Rheumatism·Guillermo Ruiz-IrastorzaMunther A Khamashta
Apr 17, 2008·Lupus·X LuS Ye
Jun 21, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Enrico ImbasciatiDaniele Marcelli
Oct 2, 2008·Lupus·R T UrbanusP G de Groot
Oct 2, 2008·Lupus·A V Kinev, R A S Roubey
Apr 17, 2009·Journal of the American Society of Nephrology : JASN·Gerald B AppelUNKNOWN Aspreva Lupus Management Study Group
Oct 31, 2009·Arthritis and Rheumatism·J BirnbaumD Kerr
Apr 27, 2010·Clinical Reviews in Allergy & Immunology·Manuel Ramos-CasalsMunther A Khamashta
Apr 29, 2010·Current Rheumatology Reports·Deepak Kumar, Robert A S Roubey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.